Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management, LLC | 2,507,125 5.730% | -1,170,614 (-31.83%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | CONNS INC CONNQ | Nantahala Capital Management, LLC | 1,389,773 5.580% | -874,805 (-38.63%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | DarioHealth Corp. DRIO | Nantahala Capital Management, LLC | 3,512,946 9.990% | 458,014 (+14.99%) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | Nantahala Capital Management, LLC | 1,682,688 6.100% | -676,453 (-28.67%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Eventbrite, Inc. EB | Nantahala Capital Management, LLC | 5,930,947 7.300% | 5,930,947 (New Position) | Filing History |
| 2025-02-03 4:47 pm Purchase | 2025-02-03 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management, LLC | 254,639 15.990% | 7 (+0.00%) | Filing History |
| 2024-12-20 4:32 pm Purchase | 2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 10,879,142 9.990% | 719,793 (+7.09%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management, LLC | 4,426,382 9.990% | 1,926,601 (+77.07%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | CONNS INC CONNQ | Nantahala Capital Management, LLC | 2,264,578 9.100% | 2,264,578 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | DarioHealth Corp. DRIO | Nantahala Capital Management, LLC | 3,054,932 9.990% | 293,792 (+10.64%) | Filing History |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | DHI Group, Inc. DHX | Nantahala Capital Management, LLC | 2,376,606 4.910% | -263,081 (-9.97%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Elutia Inc. ELUT | Nantahala Capital Management, LLC | 2,983,568 9.990% | 1,070,792 (+55.98%) | Filing History |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | enVVeno Medical Corporation NVNO | Nantahala Capital Management, LLC | 1,285,857 7.056% | -113,731 (-8.13%) | Filing History |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | Establishment Labs Holdings Inc. ESTA | Nantahala Capital Management, LLC | 2,359,141 8.543% | -111,013 (-4.49%) | Filing History |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | Evolus, Inc. EOLS | Nantahala Capital Management, LLC | 2,824,849 4.477% | -86,000 (-2.95%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Nantahala Capital Management, LLC | 4,777,912 7.657% | 4,777,912 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Aprea Therapeutics, Inc. APRE | Nantahala Capital Management, LLC | 411,520 7.300% | 411,520 (New Position) | Filing History |
| 2024-11-14 4:53 pm Unchanged | 2024-09-30 | 13G | Gaia, Inc. GAIA | Nantahala Capital Management, LLC | 915,029 5.065% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | IMAX Corporation IMAX | Nantahala Capital Management, LLC | 2,778,774 5.275% | 120,021 (+4.51%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | InspireMD, Inc. NSPR | Nantahala Capital Management, LLC | 2,607,884 9.990% | 445,492 (+20.60%) | Filing History |